U.S. surgeon general says Johnson & Johnson Covid vaccine may protect people against delta variant – CNBC
U.S. Surgeon General Dr. Vivek Murthy told CNBC on Wednesday there is reason to be hopeful that people who received the single-shot Johnson & Johnson Covid-19 vaccine may be protected against the virus' delta variant.
Murthy pointed to data that showed the Oxford-AstraZeneca shot is highly effective against hospitalization from the more contagious variant. He also said people should think of the AstraZeneca vaccine "as a cousin" to J&J's shot since it was "built on a similar platform."
"While we are still awaiting direct studies of Johnson & Johnson and the delta variant, we have reasons to be hopeful, because the J&J vaccine has proven to be quite effective against preventing hospitalizations and deaths, with all the variants that we've seen to date," Murth...